Return to PepsiAmericas Home
Cranberry
Print  |  Email

board & committees


Chairman of the Board = Chairman of the Board      Chair = Chair     Committee Member = Member   Independent Director = Independent Director
  Audit Management Resources and Compensation Affiliated Transaction Governance‚ Finance and Nominating
Herbert M. Baum Member of Audit Committee Member of Management 
Resources and 
Compensation Committee    
Richard G. Cline   Committee Chair for Management 
Resources and 
Compensation Committee Member of Affiliated 
Transaction Committee Member of Governance‚ Finance and Nominating Committee
Michael J. Corliss Member of Audit Committee Member of Management 
Resources and 
Compensation Committee    
Pierre S. du Pont Member of Audit Committee   Member of Affiliated 
Transaction Committee Committee Chair for Governance‚ Finance and Nominating Committee
Archie R. Dykes   Member of Management 
Resources and 
Compensation Committee Committee Chair for Affiliated 
Transaction Committee Member of Governance‚ Finance and Nominating Committee
Jarobin Gilbert, Jr. Committee Chair for Audit Committee     Member of Governance‚ Finance and Nominating Committee
James R. Kackley Member of Audit Committee Member of Management 
Resources and 
Compensation Committee    
Matthew M. McKenna Member of Audit Committee     Member of Governance‚ Finance and Nominating Committee
Robert C. Pohlad        
Deborah E. Powell M.D.   Member of Management 
Resources and 
Compensation Committee   Member of Governance‚ Finance and Nominating Committee
Deborah E. Powell Dean of the University of Minnesota Medical School and Assistant Vice President for Clinical Affairs
Elected 2006

Dr. Powell, 69, is Dean of the Medical School, Assistant Vice President for Clinical Affairs, and a McKnight Presidential Leadership Chair at the University of Minnesota. Dr. Powell is a board-certified surgical pathologist and medical educator with more than 30 years of experience in academic medicine. She received her medical degree from Tufts University School of Medicine. Dr. Powell served as the Vice Chair and Director of Diagnostic Pathology at the University of Kentucky in Lexington before being named Chair of the Department of Pathology and Laboratory Medicine at the same institution. In 1997, she was named Executive Dean and Vice Chancellor for Clinical Affairs at the University of Kansas School of Medicine. She came to Minnesota in the fall of 2002 to lead the University of Minnesota Medical School. She is past president of the United States and Canadian Academy of Pathology and the American Board of Pathology as well as past Chair of the Council of Deans of the Association of American Medical Colleges, and currently serves as Chair-elect of the Association of American Medical Colleges, and as a board memeber of the Fairview Health System, the University of Minnesota Medical Center – Fairview, the Minnesota Medical Foundation, and the University of Minnesota Physicians. She is a member of the Institute of Medicine of the National Academy of Sciences.

Contact the Board

You can contact PepsiAmericas, Inc.'s Board of Directors to provide comments, to report concerns, or to ask a question, at the following address.

Corporate Secretary
PepsiAmericas, Inc.
4000 RBC Plaza
Minneapolis, MN 55402
United States

You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a shareholder, customer, supplier, or other interested party.

Communications are distributed to the Board, or to any individual directors as appropriate, depending on the facts and circumstances outlined in the communication. In that regard, the PepsiAmericas, Inc. board of directors has requested that certain items which are unrelated to the duties and responsibilities of the board should be excluded, such as:

  • Product complaints
  • Product inquiries
  • New product suggestions
  • Resumes and other forms of job inquiries
  • Surveys
  • Business solicitations or advertisements

In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable will be excluded, with the provision that any communication that is filtered out must be made available to any non-management director upon request.